194 related articles for article (PubMed ID: 19902472)
1. Monocyte chemotactic protein-1 (MCP-1/CCL2) is associated with prostatic growth dysregulation and benign prostatic hyperplasia.
Fujita K; Ewing CM; Getzenberg RH; Parsons JK; Isaacs WB; Pavlovich CP
Prostate; 2010 Apr; 70(5):473-81. PubMed ID: 19902472
[TBL] [Abstract][Full Text] [Related]
2. Proliferation of Prostate Stromal Cell Induced by Benign Prostatic Hyperplasia Epithelial Cell Stimulated With Trichomonas vaginalis via Crosstalk With Mast Cell.
Kim JH; Kim SS; Han IH; Sim S; Ahn MH; Ryu JS
Prostate; 2016 Nov; 76(15):1431-44. PubMed ID: 27325623
[TBL] [Abstract][Full Text] [Related]
3. Traditional Chinese Medicine Danzhi qing'e decoction inhibits inflammation-associated prostatic hyperplasia via inactivation of ERK1/2 signal pathway.
Liu Y; Shao R; Suo T; Zhu J; Liu E; Wang Y; Miao L; Gao X
J Ethnopharmacol; 2023 Jun; 309():116354. PubMed ID: 36906158
[TBL] [Abstract][Full Text] [Related]
4. Adipocyte-derived monocyte chemotactic protein-1 (MCP-1) promotes prostate cancer progression through the induction of MMP-2 activity.
Ito Y; Ishiguro H; Kobayashi N; Hasumi H; Watanabe M; Yao M; Uemura H
Prostate; 2015 Jul; 75(10):1009-19. PubMed ID: 25917126
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-18 may lead to benign prostatic hyperplasia via thrombospondin-1 production in prostatic smooth muscle cells.
Hamakawa T; Sasaki S; Shibata Y; Imura M; Kubota Y; Kojima Y; Kohri K
Prostate; 2014 May; 74(6):590-601. PubMed ID: 24615654
[TBL] [Abstract][Full Text] [Related]
6. Monocyte chemoattractant protein-1 gene expression in prostatic hyperplasia and prostate adenocarcinoma.
Mazzucchelli L; Loetscher P; Kappeler A; Uguccioni M; Baggiolini M; Laissue JA; Mueller C
Am J Pathol; 1996 Aug; 149(2):501-9. PubMed ID: 8701989
[TBL] [Abstract][Full Text] [Related]
7. Hexanic lipidosterolic extract of Serenoa repens inhibits the expression of two key inflammatory mediators, MCP-1/CCL2 and VCAM-1, in vitro.
Latil A; Libon C; Templier M; Junquero D; Lantoine-Adam F; Nguyen T
BJU Int; 2012 Sep; 110(6 Pt B):E301-7. PubMed ID: 22520557
[TBL] [Abstract][Full Text] [Related]
8. M2a macrophage can rescue proliferation and gene expression of benign prostate hyperplasia epithelial and stroma cells from insulin-like growth factor 1 knockdown.
Qian Q; He W; Liu D; Yin J; Ye L; Chen P; Xu D; Liu J; Li Y; Zeng G; Li M; Wu Z; Zhang Y; Wang X; DiSanto ME; Zhang X
Prostate; 2021 Jun; 81(9):530-542. PubMed ID: 33861464
[TBL] [Abstract][Full Text] [Related]
9. Monocyte chemotactic protein-1 (MCP-1) acts as a paracrine and autocrine factor for prostate cancer growth and invasion.
Lu Y; Cai Z; Galson DL; Xiao G; Liu Y; George DE; Melhem MF; Yao Z; Zhang J
Prostate; 2006 Sep; 66(12):1311-8. PubMed ID: 16705739
[TBL] [Abstract][Full Text] [Related]
10. Regulation of cell proliferation through a KIT-mediated mechanism in benign prostatic hyperplasia.
Imura M; Kojima Y; Kubota Y; Hamakawa T; Yasui T; Sasaki S; Hayashi Y; Kohri K
Prostate; 2012 Oct; 72(14):1506-13. PubMed ID: 22314612
[TBL] [Abstract][Full Text] [Related]
11. Cell-associated human retinal pigment epithelium interleukin-8 and monocyte chemotactic protein-1: immunochemical and in-situ hybridization analyses.
Elner VM; Burnstine MA; Strieter RM; Kunkel SL; Elner SG
Exp Eye Res; 1997 Dec; 65(6):781-9. PubMed ID: 9441701
[TBL] [Abstract][Full Text] [Related]
12. Monocyte chemotactic protein-1 mediates prostate cancer-induced bone resorption.
Lu Y; Cai Z; Xiao G; Keller ET; Mizokami A; Yao Z; Roodman GD; Zhang J
Cancer Res; 2007 Apr; 67(8):3646-53. PubMed ID: 17440076
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of lymphocyte-derived cytokines in benign hyperplastic prostate tissue, identification of the producing cell types, and effect of differentially expressed cytokines on stromal cell proliferation.
Kramer G; Steiner GE; Handisurya A; Stix U; Haitel A; Knerer B; Gessl A; Lee C; Marberger M
Prostate; 2002 Jun; 52(1):43-58. PubMed ID: 11992619
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory Responses in a Benign Prostatic Hyperplasia Epithelial Cell Line (BPH-1) Infected with Trichomonas vaginalis.
Kim SS; Kim JH; Han IH; Ahn MH; Ryu JS
Korean J Parasitol; 2016 Apr; 54(2):123-32. PubMed ID: 27180569
[TBL] [Abstract][Full Text] [Related]
15. Antiproliferative activity of angiotensin II receptor blocker through cross-talk between stromal and epithelial prostate cancer cells.
Uemura H; Ishiguro H; Nagashima Y; Sasaki T; Nakaigawa N; Hasumi H; Kato S; Kubota Y
Mol Cancer Ther; 2005 Nov; 4(11):1699-709. PubMed ID: 16275991
[TBL] [Abstract][Full Text] [Related]
16. Prostatic osteopontin expression is associated with symptomatic benign prostatic hyperplasia.
Popovics P; Awadallah WN; Kohrt SE; Case TC; Miller NL; Ricke EA; Huang W; Ramirez-Solano M; Liu Q; Vezina CM; Matusik RJ; Ricke WA; Grabowska MM
Prostate; 2020 Jul; 80(10):731-741. PubMed ID: 32356572
[TBL] [Abstract][Full Text] [Related]
17. Dysregulation of Dkk-3 expression in benign and malignant prostatic tissue.
Zenzmaier C; Untergasser G; Hermann M; Dirnhofer S; Sampson N; Berger P
Prostate; 2008 Apr; 68(5):540-7. PubMed ID: 18247400
[TBL] [Abstract][Full Text] [Related]
18. Monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha as possible biomarkers for the chronic pelvic pain syndrome.
Desireddi NV; Campbell PL; Stern JA; Sobkoviak R; Chuai S; Shahrara S; Thumbikat P; Pope RM; Landis JR; Koch AE; Schaeffer AJ
J Urol; 2008 May; 179(5):1857-61; discussion 1861-2. PubMed ID: 18353390
[TBL] [Abstract][Full Text] [Related]
19. Human retinal pigment epithelial cell interleukin-8 and monocyte chemotactic protein-1 modulation by T-lymphocyte products.
Elner SG; Elner VM; Bian ZM; Lukacs NW; Kurtz RM; Strieter RM; Kunkel SL
Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):446-55. PubMed ID: 9040478
[TBL] [Abstract][Full Text] [Related]
20. The effect of oxytocin on cell proliferation in the human prostate is modulated by gonadal steroids: implications for benign prostatic hyperplasia and carcinoma of the prostate.
Whittington K; Connors B; King K; Assinder S; Hogarth K; Nicholson H
Prostate; 2007 Jul; 67(10):1132-42. PubMed ID: 17492653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]